Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Dental Treatment
Study Details
Study Description
Brief Summary
Dexmedetomidine is a drug known for its pain-relieving and restlessness-reducing effects. The purpose of this run is to use the association between this use during surgery and the attrition of post-operative pain and discomfort. In the research, laboratory and monitoring results will be obtained before, during and after the operation. Postoperative patient complaints will be evaluated at the postoperative service visit. This study is decided on a completely voluntary basis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Dex patients using dexmedetomidine infusion |
Drug: Dexmedetomidine
In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.
Other Names:
|
Fen patients using fentanyl for induction |
Drug: Fentanyl
In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- postoperative pain [Pain was evaluated at 0, 2, 4, 6 and 8 hours postoperatively.]
Postoperative pain level will be measured using the FLACC pain scale (face, legs, activity, cry, consolability). 4 and above will be considered as high pain level, below 4 as low pain level.
- postoperative anxiety [anxiety was evaluated at 0, 2, 4, 6 and 8 hours postoperatively.]
Postoperative anxiety level will be measured using the Pediatric Anesthesia Emergence Delirium Scale (PAED). A value of 12 and above will be considered high anxiety, and values below 12 will be considered low anxiety.
Eligibility Criteria
Criteria
Exclusion Criteria:
Inclusion Criteria:
Patients with ASA 1-2, aged 2-10 years, scheduled for elective tonsillectomy and/or adenoidectomy operation will be included.
Exclusion Criteria:
developmental delay anxiety disorder Known history of allergy to alpha-2 agonistic agents use of antipsychotic medication beta blocker use of anticonvulsant drugs chronic pain syndrome with cardiac and craniofacial anomalies
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Istanbul Medipol University | Istanbul | Turkey | 34400 |
Sponsors and Collaborators
- Medipol University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- E-10840098-772.02-6155